Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 4
2005 2
2006 3
2007 1
2008 2
2009 1
2010 2
2011 1
2012 2
2013 2
2014 5
2015 1
2016 1
2017 2
2018 2
2019 7
2020 9
2021 12
2022 4
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
The Novel SSTR3 Agonist ITF2984 Exerts Antimitotic and Proapoptotic Effects in Human Non-Functioning Pituitary Neuroendocrine Tumor (NF-PitNET) Cells.
Di Muro G, Catalano R, Treppiedi D, Barbieri AM, Mangili F, Marra G, Di Bari S, Esposito E, Nozza E, Lania AG, Ferrante E, Locatelli M, Modena D, Steinkuhler C, Peverelli E, Mantovani G. Di Muro G, et al. Among authors: ferrante e. Int J Mol Sci. 2024 Mar 23;25(7):3606. doi: 10.3390/ijms25073606. Int J Mol Sci. 2024. PMID: 38612419 Free PMC article.
A pharmacoeconomic analysis from Italian guidelines for the management of prolactinomas.
Basile M, Valentini I, Attanasio R, Cozzi R, Persichetti A, Samperi I, Scoppola A, Auriemma RS, De Menis E, Esposito F, Ferrante E, Iatì G, Mazzatenta D, Poggi M, Rudà R, Tortora F, Cruciani F, Mitrova Z, Saulle R, Vecchi S, Cappabianca P, Paoletta A, Bozzao A, Caputo M, Doglietto F, Ferraù F, Lania AG, Laureti S, Lello S, Locatelli D, Maffei P, Minniti G, Peri A, Ruini C, Settanni F, Silvani A, Veronese N, Grimaldi F, Papini E, Cicchetti A. Basile M, et al. Among authors: ferrante e. Glob Reg Health Technol Assess. 2024 Jan 9;11:1-16. doi: 10.33393/grhta.2024.2601. eCollection 2024 Jan-Dec. Glob Reg Health Technol Assess. 2024. PMID: 38230389 Free PMC article.
High Filamin a Expression in Adrenocortical Carcinomas Is Associated with a Favourable Tumour Behaviour: A European Multicentric Study.
Catalano R, Altieri B, Angelousi A, Arosio M, Bravi F, Canu L, Croci GA, Detomas M, Esposito E, Ferrante E, Ferrero S, Fuss CT, Kaltsas G, Kimpel O, Landwehr LS, Luconi M, Morelli V, Nesi G, Nozza E, Sbiera S, Serban AL, Ronchi CL, Mantovani G, Peverelli E. Catalano R, et al. Among authors: ferrante e. Int J Mol Sci. 2023 Nov 21;24(23):16573. doi: 10.3390/ijms242316573. Int J Mol Sci. 2023. PMID: 38068896 Free PMC article.
Arginine or Hypertonic Saline-Stimulated Copeptin to Diagnose AVP Deficiency.
Refardt J, Atila C, Chifu I, Ferrante E, Erlic Z, Drummond JB, Indirli R, Drexhage RC, Sailer CO, Widmer A, Felder S, Powlson AS, Hutter N, Vogt DR, Gurnell M, Soares BS, Hofland J, Beuschlein F, Fassnacht M, Winzeler B, Christ-Crain M. Refardt J, et al. Among authors: ferrante e. N Engl J Med. 2023 Nov 16;389(20):1877-1887. doi: 10.1056/NEJMoa2306263. N Engl J Med. 2023. PMID: 37966286 Clinical Trial.
The association of hypogonadism with depression and its treatments.
Indirli R, Lanzi V, Arosio M, Mantovani G, Ferrante E. Indirli R, et al. Among authors: ferrante e. Front Endocrinol (Lausanne). 2023 Aug 10;14:1198437. doi: 10.3389/fendo.2023.1198437. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37635965 Free PMC article. Review.
A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells.
Di Muro G, Mangili F, Esposito E, Barbieri AM, Catalano R, Treppiedi D, Marra G, Nozza E, Lania AGA, Ferrante E, Locatelli M, Arosio M, Peverelli E, Mantovani G. Di Muro G, et al. Among authors: ferrante e. Cancers (Basel). 2023 Jun 16;15(12):3218. doi: 10.3390/cancers15123218. Cancers (Basel). 2023. PMID: 37370829 Free PMC article.
Italian Guidelines for the Management of Prolactinomas.
Cozzi R, Simona Auriemma R, De Menis E, Esposito F, Ferrante E, Iatì G, Mazzatenta D, Poggi M, Rudà R, Tortora F, Cruciani F, Mitrova Z, Saulle R, Vecchi S, Basile M, Cappabianca P, Paoletta A, Papini E, Persichetti A, Samperi I, Scoppola A, Bozzao A, Caputo M, Doglietto F, Ferraù F, Lania AG, Laureti S, Lello S, Locatelli D, Maffei P, Minniti G, Peri A, Ruini C, Settanni F, Silvani A, Veronese N, Grimaldi F, Attanasio R. Cozzi R, et al. Among authors: ferrante e. Endocr Metab Immune Disord Drug Targets. 2023;23(12):1459-1479. doi: 10.2174/1871530323666230511104045. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 37171003 Free PMC article.
Predicting tumor consistency and extent of resection in non-functioning pituitary tumors.
Fiore G, Bertani GA, Conte G, Ferrante E, Tariciotti L, Kuhn E, Runza L, Pluderi M, Borsa S, Caroli M, Sala E, Platania G, Kremenova K, Ferrero S, Triulzi FM, Mantovani G, Locatelli M. Fiore G, et al. Among authors: ferrante e. Pituitary. 2023 Apr;26(2):209-220. doi: 10.1007/s11102-023-01302-x. Epub 2023 Feb 20. Pituitary. 2023. PMID: 36808379
Effects of the therapy shift from cortisone acetate to modified-release hydrocortisone in a group of patients with adrenal insufficiency.
Frigerio S, Carosi G, Ferrante E, Sala E, Polledri E, Fustinoni S, Ambrosi B, Chiodini I, Mantovani G, Morelli V, Arosio M. Frigerio S, et al. Among authors: ferrante e. Front Endocrinol (Lausanne). 2023 Jan 24;14:1093838. doi: 10.3389/fendo.2023.1093838. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36761196 Free PMC article.
67 results